The post Pump.fun team moves 1.75B PUMP: Can bulls offset selling pressure? appeared on BitcoinEthereumNews.com. Pump.fun [PUMP] has remained largely neutral toThe post Pump.fun team moves 1.75B PUMP: Can bulls offset selling pressure? appeared on BitcoinEthereumNews.com. Pump.fun [PUMP] has remained largely neutral to

Pump.fun team moves 1.75B PUMP: Can bulls offset selling pressure?

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Pump.fun [PUMP] has remained largely neutral to developments over the past day involving the project’s team.

For now, market sentiment will depend mainly on the actions of retail investors and on-chain users of the platform, as participants assess whether the next move will be a short-term rally or a further decline.

Team transfers tokens to the exchange

Recent on‑chain activity indicates movement linked to the team behind the asset.

Data indicates that in the early hours of the 6th of March, a wallet linked to Pump.fun executed two transactions that transferred its native token, PUMP, to the cryptocurrency exchange Bitget.

The first transaction involved the sale of 1.75 billion PUMP, valued at roughly $3.54 million. The second transaction transferred 5,000 PUMP tokens, worth about $10.

Transfers from private wallets to centralized exchanges often raise concerns about a potential sell-off, as such movements typically increase the likelihood of tokens entering the market.

Despite the transfers, the market has yet to show strong volatility. PUMP’s price has declined by 1.73%, while trading volume has dropped 21% to around $100 million during the same period.

Market absorbs potential selling pressure

So far, spot exchange netflow data shows no clear evidence of a large-scale sell-off.

This metric tracks the inflow and outflow of an asset on exchanges to determine whether buyers or sellers currently dominate market activity.

According to CoinGlass data, investors have continued to buy PUMP over the past five days, beginning on the 2nd of March, with average daily purchases of about $691,000.

Source: CoinGlass

However, a broader market indicator presents a different picture. The Accumulation/Distribution (A/D) indicator, which measures whether investors are accumulating or distributing an asset over time, suggests that selling pressure still dominates.

Chart data shows that the distribution has persisted for several months, dating back to November 2025. In the past 24 hours alone, roughly 6 billion PUMP tokens entered circulation, indicating continued distribution into the market.

The divergence between recent spot buying and the longer-term A/D reading suggests that current accumulation remains relatively weak. This aligns with the modest average buying activity recorded over the past five days.

On-chain activity remains stable

Despite the market uncertainty, on-chain activity across the Pump.fun ecosystem remains relatively steady.

Launchpad volume on the platform continues to climb, indicating sustained activity that could support demand for the token.

Data from Artemis shows that launchpad volume currently stands at $101.8 million, marking the second-highest level recorded this year.

Source: Artemis

The highest level occurred on the 2nd of March, when volume reached $105.2 million. Before this recent surge, the last time launchpad activity approached similar levels was in October 2025.

Rising platform usage could gradually support overall demand and strengthen PUMP’s value over time. One metric worth monitoring closely is the platform’s daily revenue.

At present, Pump.fun generates around $1.3 million in revenue per day, reflecting sustained activity across the ecosystem.


Final Summary

  • The PUMP team moved part of its holdings to a centralized exchange, raising speculation about a potential sell-off.
  • Daily buying averages around $691,000, but declining accumulation across the broader trend leaves PUMP exposed to downside risk.
Next: Altcoin interest falls: Could an Ethereum breakout spark altseason?

Source: https://ambcrypto.com/pump-fun-team-moves-1-75b-pump-can-bulls-offset-selling-pressure/

Market Opportunity
pump.fun Logo
pump.fun Price(PUMP)
$0,0019
$0,0019$0,0019
%0,00
USD
pump.fun (PUMP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09